Display Settings:

Format
Sort by

Send to:

Choose Destination

Results: 5

1.

Reduced anxiety and depression-like behavior in synaptotagmin IV (-/-) mice.

Ferguson GD, Herschman HR, Storm DR.

Neuropharmacology. 2004 Sep;47(4):604-11.

PMID:
15380377
[PubMed - indexed for MEDLINE]
2.

Synaptotagmin IV: biochemistry, genetics, behavior, and possible links to human psychiatric disease.

Ferguson GD, Vician L, Herschman HR.

Mol Neurobiol. 2001 Apr-Jun;23(2-3):173-85. Review.

PMID:
11817218
[PubMed - indexed for MEDLINE]
3.

The synaptotagmins: calcium sensors for vesicular trafficking.

Yoshihara M, Montana ES.

Neuroscientist. 2004 Dec;10(6):566-74. Review.

PMID:
15534041
[PubMed - indexed for MEDLINE]
4.

Behavioral and serotonergic consequences of decreasing or increasing hippocampus brain-derived neurotrophic factor protein levels in mice.

Deltheil T, Guiard BP, Cerdan J, David DJ, Tanaka KF, Repérant C, Guilloux JP, Coudoré F, Hen R, Gardier AM.

Neuropharmacology. 2008 Nov;55(6):1006-14. doi: 10.1016/j.neuropharm.2008.08.001. Epub 2008 Aug 12. Review.

PMID:
18761360
[PubMed - indexed for MEDLINE]
5.

Anxiety and depression: mouse genetics and pharmacological approaches to the role of GABA(A) receptor subtypes.

Smith KS, Rudolph U.

Neuropharmacology. 2012 Jan;62(1):54-62. doi: 10.1016/j.neuropharm.2011.07.026. Epub 2011 Jul 27. Review.

PMID:
21810433
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk